The article presents February 16, 2016 news briefs from the U.S. Food and Drug Administration (FDA). FDA has issued two orders regarding the serious complications associated with surgical mesh used for transvaginal repair of pelvic organ prolapse. FDA has approved the attempt of Lesinurad to decrease high uric acid levels in the blood that cause gout, a form of arthritis.